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Reduced intestinal and renal amino acid transport in PDK1
hypomorphic mice
Abstract
The phosphoinositide-dependent kinase PDK1 activates the serum- and glucocorticoid-inducible kinase
isoforms SGK1, SGK2, and SGK3 and protein kinase B, which in turn are known to up-regulate a
variety of sodium-coupled transporters. The present study was performed to explore the role of PDK1 in
amino acid transport. As mice completely lacking functional PDK1 are not viable, mice expressing
10-25% of PDK1 (pdk1(hm)) were compared with their wild-type (WT) littermates (pdk1(wt)). Body
weight was significantly less in pdk1(hm) than in pdk1(wt) mice. Despite lower body weight of
pdk1(hm) mice, food and water intake were similar in pdk1(hm) and pdk1(wt) mice. According to
Ussing chamber experiments, electrogenic transport of phenylalanine, cysteine, glutamine, proline,
leucine, and tryptophan was significantly smaller in jejunum of pdk1(hm) mice than in pdk1(wt) mice.
Similarly, electrogenic transport of phenylalanine, glutamine, and proline was significantly decreased in
isolated perfused proximal tubules of pdk1(hm) mice. The urinary excretion of proline, valine,
guanidinoacetate, methionine, phenylalanine, citrulline, glutamine/glutamate, and tryptophan was
significantly larger in pdk1(hm) than in pdk1(wt) mice. According to immunoblotting of brush border
membrane proteins prepared from kidney, expression of the Na+-dependent neutral amino acid
transporter B(0)AT1 (SLC6A19), the glutamate transporter EAAC1/EAAT3 (SLC1A1), and the
transporter for cationic amino acids and cystine b(0,+)AT (SLC7A9) was decreased but the Na+/proline
cotransporter SIT (SLC6A20) was increased in pdk1(hm) mice. In conclusion, reduction of functional
PDK1 leads to impairment of intestinal absorption and renal reabsorption of amino acids. The combined
intestinal and renal loss of amino acids may contribute to the growth defect of PDK1-deficient mice.
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ABSTRACT The phosphoinositide-dependent kinase
PDK1 activates the serum- and glucocorticoid-inducible
kinase isoforms SGK1, SGK2, and SGK3 and protein
kinase B, which in turn are known to up-regulate a
variety of sodium-coupled transporters. The present
study was performed to explore the role of PDK1 in
amino acid transport. As mice completely lacking func-
tional PDK1 are not viable, mice expressing 10–25% of
PDK1 (pdk1hm) were compared with their wild-type
(WT) littermates (pdk1wt). Body weight was significantly
less in pdk1hm than in pdk1wtmice. Despite lower body
weight of pdk1hmmice, food and water intake were
similar in pdk1hm and pdk1wtmice. According to Ussing
chamber experiments, electrogenic transport of phe-
nylalanine, cysteine, glutamine, proline, leucine, and
tryptophan was significantly smaller in jejunum of
pdk1hmmice than in pdk1wtmice. Similarly, electrogenic
transport of phenylalanine, glutamine, and proline was
significantly decreased in isolated perfused proximal
tubules of pdk1hmmice. The urinary excretion of pro-
line, valine, guanidinoacetate, methionine, phenylala-
nine, citrulline, glutamine/glutamate, and tryptophan
was significantly larger in pdk1hm than in pdk1wtmice.
According to immunoblotting of brush border mem-
brane proteins prepared from kidney, expression of
the Na-dependent neutral amino acid transporter
B0AT1 (SLC6A19), the glutamate transporter EAAC1/
EAAT3 (SLC1A1), and the transporter for cationic
amino acids and cystine b0,AT (SLC7A9) was de-
creased but the Na/proline cotransporter SIT
(SLC6A20) was increased in pdk1hm mice. In conclusion,
reduction of functional PDK1 leads to impairment of
intestinal absorption and renal reabsorption of amino
acids. The combined intestinal and renal loss of amino
acids may contribute to the growth defect of PDK1-
deficient mice.—Rexhepaj, R., Grahammer, F., Vo¨lkl, H.,
Remy, C., Wagner, C. A., Sandulache, D., Artunc, F.,
Henke, G., Nammi, S., Capasso, G., Alessi, D. R., Lang, F.
Reduced intestinal and renal amino acid transport in
PDK1 hypomorphic mice. FASEB J. 20, 2214–2222 (2006)
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IN VITRO coexpression studies in Xenopus oocytes
disclosed the ability of protein kinase B/Akt (1, 2) and
the serum- and glucocorticoid-inducible kinase family
members SGK1 (3–5), SGK2 (6), and SGK3 (6) to
up-regulate a variety of channels and transporters (7–
10), including the glutamine transporter SN1
(SLC38A3, SNAT3) (11) as well as glutamate transport-
ers EAAT1 (SLCA3) (12), EAAT2 (SCL1A2) (13),
EAAT3 (SLC1A1) (14), EAAT4 (SLC1A6) (15), and
EAAT5 (SLC1A7) (16).
PKB and SGKs are activated by IGF1 and insulin
through the phosphatidylinositide 3 (PI3) kinase and
phosphoinositide-dependent kinase PDK1 (17–23).
The PI3 kinase pathway is an integral element of
growth factor, insulin, and IFN signaling (24–29). Its
pleotropic functions include regulation of cell survival
(30, 31) and cell proliferation (32–35). Moreover,
inactivation of PDK1 by the phosphatase PTEN is
abrogated by oxidation, and thus PDK1 participates in
the signaling of oxidative stress (36). In view of its
influence on the PKB and SGK isoforms, PDK1 may be
a master switch in the growth factor-, insulin-, and
stress-dependent regulation of amino acid transport.
The PDK1 knockout mouse is not viable (37), high-
lighting the functional importance of this kinase. Mice
with suppressed PDK1 activity of up to 20% (pdk1hm)
are significantly smaller than their age- and sex-
matched WT littermates (pdk1wt) (37). The smaller
weight of the animals appeared to be primarily due to
decreased cell volumes and not to cell number (37).
Among the determinants of cell volume is the concen-
trative cellular uptake of amino acids (38–40). The
present study was performed to elucidate the impact of
PDK1 on transport of amino acids in the intestine and
the kidney.
Several amino acid transport systems in mammals
contribute to the intestinal absorption or renal proxi-
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mal tubular reabsorption of amino acids (41–43).
Neutral amino acids are mainly transported by the
Na-dependent system B0 and IMINO encoded by the
B0AT1 (SLC6A19) and SIT (SLC6A20) (43–46). Ac-
cordingly, mutations in B0AT1 are responsible for
Hartnup disease characterized by the impaired trans-
port of neutral amino acids in the intestine and renal
proximal tubule (47, 48). Anionic amino acids are
transported in a Na- and K-dependent manner by
the system XAG EAAC1/EAAT3 (SLC1A1) trans-
porter, whereas cationic amino acids and cystine are
transported by the dimeric b0,AT/rBAT (SLC7A9/
SLC3A1) transporter. Mutations in either b0,AT or
rBAT cause cystinuria with reduced transport of these
amino acids both in intestine and kidney (42–49). So
far, little if anything is known about the regulation of
these transport systems in vivo.
MATERIALS AND METHODS
Animals
Generation and basic properties of PDK1 hypomorphic mice
have been described (37). Genotyping was made by polymer-
ase chain reaction (PCR) on tail DNA using PDK1 and
neo-R-specific primers as described previously (37). Mice had
free access to standard mouse diet (C14310 Altromin, Lan-
gen, Germany) and tap water. All animal experiments were
conducted according to the guidelines of The American
Physiological Society, German law for the welfare of animals
and were approved by the local authorities.
Food intake, fecal weight, and electrolyte composition
Mice were placed in individual metabolic cages (Tecniplast,
Hohenpeissenberg, Germany). After a training period of 2
days, food and fluid intake as well as urinary and fecal output
were determined under control conditions (control diet
C1000 Altromin, Germany) over two consecutive 24 h peri-
ods. Results were averaged for each animal. The inner wall of
the metabolic cages was siliconized and urine was collected
under water-saturated oil to allow for quantitative measure-
ments. Before and at the end of the metabolic cage experi-
ments, 150 l blood was withdrawn into heparinized capil-
laries by puncturing the retro-orbital plexus. Hematocrit was
determined after centrifugation. Plasma was separated for
further analysis. Serum insulin-like growth factor (IGF) 1 was
measured using an ELISA kit according to the manufacturer’s
instructions (DSL-10–2900, dsl, Webster, TX, USA).
To determine amino acid concentrations in urine, mice
were individually placed in metabolic cages and urine was
collected over 24 h. To prevent bacterial growth and hence
metabolism and breakdown of amino acids, 5 l of concen-
trated acetic acid was added into the urine collectors beneath
the mineral oil. Amino acid concentrations in urine and serum
were measured by HPLC as described before (8). Urinary
creatinine concentrations were determined utilizing a commer-
cial enzymatic kit (Labor und Technik, Berlin, Germany).
Electrogenic amino acid transport in isolated perfused
proximal straight tubules
Experiments have been performed in proximal straight tu-
bules. Segments of 0.2 to 0.4 mm length were dissected and
perfused following principally the method of Burg et al. (50).
Modifications of the technique concerning track system,
pipette arrangement, and use of dual channel perfusion
pipettes have been described in detail previously (51, 52).
The luminal perfusion rate was 10 nl/min. The bath was
continuously perfused at a rate of 20 ml/min and thermo-
stated with a dual channel feedback system (Hampel, Frank-
furt, Germany). Bath temperature was kept constant at 38°C.
The potential difference across the basolateral cell mem-
brane (PDbl) was determined utilizing Ling-Gerard elec-
trodes (100–200 M) pulled from filament capillaries (1.5
o.d., 1.0 i.d., Hilgenberg, Malsfeld; Germany). The electrodes
were connected to a high impedance electrometer (FD223,
WPI, Science Trading, Frankfurt, Germany) via an Ag/AgCl
half cell. An Ag/AgCl reference electrode was connected to
the bath. Entry of positive charge by electrogenic transport is
expected to depolarize the basolateral cell membrane. The
magnitude of the depolarization depends on the magnitude
of the induced current on the one hand and on the resistance
of cell membranes and shunt on the other. PDbl was contin-
uously recorded with and without l-phenylalanine, l-glu-
tamine, or l-proline (20 mM each) in the luminal perfusate
to stimulate electrogenic reabsorption as described (53). The
bath and luminal perfusates were composed of (all numbers
mM): 110 NaCl, 5 KCl, 20 NaHCO3, 1.3 CaCl2, 1 MgCl2, and
2 Na2HPO4. In the bath, (in mM) 18 mannitol, 1 glucose
(Glc), 1 glutamine, and 1 Na-lactate; 20 mannitol and 1 Ba2
were added and in the lumen. Where indicated, 20 mM
mannitol was replaced by 20 mM of the respective amino acid
in the luminal perfusate. The bath solution was constantly
gassed with a mixture of 95% O2 and 5% CO2, resulting in a pH
of 7.4.
Ussing chamber experiments in small intestine
For analysis of electrogenic intestinal amino acid transport,
animals were sacrificed, the abdomen was opened, and the
intestine was quickly removed. Jejunal segments (5 to 10 cm
postpylorus) were mounted into a custom-made mini-Ussing
chamber with an opening diameter of 0.99 mm and an
opening area of 0.00769 cm2. Under control conditions, the
serosal and luminal perfusate contained (in mM): 115 NaCl,
2 KCl, 1 MgCl2, 1.25 CaCl2, 0.4 KH2PO4, 1.6 K2HPO4, 5 Na
pyruvate, 25 NaHCO3, 20 mannitol (pH 7.4, adjusted with
HCl). Where indicated, l-phenylalanine, l-cysteine, l-glu-
tamine, l-proline, l-leucine, l-tryptophan, l-valine, l-methio-
nine, and l-citrulline (20 mM, all from Roth, Karlsruhe,
Germany) were added to the luminal perfusate at the expense
of mannitol.
In all Ussing chamber experiments, the transepithelial
potential difference (Vte) was determined continuously and
transepithelial resistance (Rte) was estimated from the voltage
deflections (Vte) elicited by imposing test currents (It1
A). The resulting Rte and the short circuit current (Isc) were
calculated according to Ohm’s law. All substances were from
Sigma (Taufkirchen, Germany) or Roth (Karlsruhe, Ger-
many).
Preparation of brush border membrane vesicles (BBMV)
BBMV were prepared from whole mouse kidney using the
Mg2 precipitation technique as described (54) After mea-
surement of the total protein concentration (Bio-Rad Protein
kit, Bio-Rad, Hercules, CA, USA), 20 g of brush border
membrane protein was solubilized in Laemmli sample buffer
and SDS-PAGE was performed on 10% polyacrylamide gels.
For immunoblotting, proteins were transferred electro-
phoretically from unstained gels to PVDF membranes (Im-
mobilon-P, Millipore, Bedford, MA, USA). After blocking
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with 5% milk powder in Tris-buffered saline/0.1% Tween-20
for 60 min, the blots were incubated with affinity purified
rabbit anti-B0AT1 (SLC6A19), rabbit anti-SIT (SLC6A20)
(46), rabbit anti-EAAC1/EAAT3 (SLC1A1) (Alpha Diagnos-
tics, San Antonio, TX, USA), rabbit antib0,AT1 (SLC7A9)
antibodies (1:1000), and mouse monoclonal antiactin (42
kDa, Sigma) 1: 500 either for 2 h at room temperature or
overnight at 4°C. After washing and subsequent blocking,
blots were incubated with secondary antibodies conjugated
with alkaline phosphatase or horseradish peroxidase (goat
anti-rabbit 1:5000 and donkey anti-mouse 1:5000; Promega,
Madison, WI, USA) for 1 h at room temperature. Antibody
(Ab) binding was detected with the enhanced chemilumines-
cence (ECL) kit (Pierce, Rockford, IL, USA) in the case of
HRP-linked antibodies and with the CDP Star kit (Roche,
Nutley, NJ, USA) for activating protein (AP) linked antibod-
ies before detection of chemiluminescence with the Diana III
Chemiluminescence detection system. Bands were quantified
with the Aida Image Analyzer software (Raytest, Strauben-
hardt, Germany).
Statistics
Data are provided as means 	 se; n represents the number of
independent experiments. All data were tested for signifi-
cance using the unpaired Student’s t test with Welch correc-
tion, where applicable, and only results with P 
 0.05 were
considered statistically significant.
RESULTS
As reported earlier, at the same age (32–36 wk) body
weight was significantly smaller in pdk1hm mice
(22.5	0.9 g, n12) than in pdk1wt mice (32.7	1.3 g,
n12). Despite lower body weight of pdk1hm mice, food
and water intake were similar in pdk1hm mice (3.8	0.2
g/24 h and 4.4	0.4 ml/24 h, respectively) as in pdk1wt
mice (3.2	0.1 g/24 h and 4.2	0.5 ml/24 h, respec-
tively). Consequently, if expressed per gram body
weight, food and water intake were significantly larger
in pdk1hm than pdk1wt mice (Fig. 1).
In theory, growth retardation could result from de-
fective release of growth hormone leading to decreased
formation of IGF1. To explore this possibility, we
determined plasma IGF-1 concentrations in both wean-
ing (18 days) and adult (4 months) animals. However,
the respective values were not significantly different
between pdk1hm mice (338	43 ng/ml and 454	44
ng/ml, respectively, n7–9) and pdk1wt mice (332	13
ng/ml and 483	64 ng/ml, respectively, n7–9).
Additional experiments were performed to deter-
mine whether altered weight was paralleled by altered
intestinal transport. To determine PDK1-dependent
amino acid transport, segments of jejunum from pdk1hm
and pdk1wt mice were mounted into mini-Ussing cham-
bers and electrogenic amino acid transport was deter-
mined utilizing electrophysiological analysis (Fig. 2). In
the absence of luminal substrates, the transepithelial
potential difference (Vte) of jejunal segments
amounted to –4.17 	 0.33 mV (n13) in pdk1hm mice
and to –4.11 	 0.24 mV (n14) in pdk1wt mice. The
transepithelial resistance (Rte) approached 9.4 	 0.7 
 cm2 (n13) in pdk1hm mice and 8.3 	 0.4   cm2
Figure 1. Body weight, food and water intake (per 24h) in
pdk1hmand pdk1wt mice. Arithmetic means 	 se (n12) of
body weight, food and water intake of PDK1 hypomorphic
mice (pdk1hm, filled columns) and WT littermates (pdk1wt,
open columns). *Statistically significant difference between
pdk1hm and pdk1wt mice.
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(n14) in pdk1wt mice. Neither transepithelial poten-
tial difference nor transepithelial resistance were signif-
icantly different between pdk1hm and pdk1wt mice.
Accordingly, calculated basal short circuit current
(Isc, basal) was not different between the two genotypes,
reaching –472 	 56 A/cm2 in pdk1hm mice and
–514 	 46 A/cm2 in pdk1wt mice, respectively.
The iso-osmotic replacement of mannitol by phenyl-
alanine, cysteine, glutamine, proline, or leucine cre-
ated a lumen-negative shift of the transepithelial poten-
tial difference (Vaa) without significantly altering the
transepithelial resistance. The Vaa and Rte allowed
calculation of the amino acid-induced short circuit
current (Isc,aa). The Isc,aa was smaller in pdk1
hm than in
pdk1wt mice, a difference reaching statistical signifi-
cance for phenylalanine, cysteine, glutamine, proline,
leucine, and tryptophan (Table 1, Fig. 2). The currents
induced by methionine, valine, and citrulline tended to
be lower in pdk1hm mice, a difference that did not reach
statistical significance between the genotypes, however
(Table 1, Fig. 2).
Similar to intestine, proximal renal tubules display
decreased electrogenic transport of amino acids in
PDK1hm mice. As illustrated in Fig. 3, the potential
difference across the basolateral cell membrane (PDbl)
of isolated perfused straight proximal tubules (i.e., late
parts of proximal tubule) was in the absence of amino
acids not significantly different between pdk1hm mice
(–51.4	2.5, n13) and pdk1wt mice (–54.4	1.5 mV,
n14). Addition of 20 mM l-phenylalanine, l-glu-
Figure 2. Amino acid-induced short circuit current (Isc,aa) in proximal jenunal segments. Alterations of transepithelial voltages
(Vaa) and induced short circuit currents (Isc,aa) in proximal segments of jejunal tissue from PDK1 hypomorphic mice (pdk1
hm)
and WT littermates (pdk1wt) before and after addition of phenylalanine (Phe), cysteine (Cys), glutamine (Gln), proline (Pro),
leucine (Leu), tryptophan (Try), methionine (Met), valine (Val), and citrulline (Cit). A) Original tracings illustrating the effect
of amino acids on the transepithelial potential difference. B) Arithmetic means 	 se (n13–14) of amino acid-induced short
circuit currents in jejunum from pdk1hm mice (open columns) and pdk1wt mice (filled columns). * Statistically significant
difference between pdk1hm and pdk1wt mice.
TABLE 1. Amino acid induced currents in jejunuma
Amino acid
Current in
pdk1wt
Current in
pdk1hm n
Phenylalanine –373 	 33 –245 	 44* 13–14
Cysteine –389 	 47 –243 	 35* 13–14
Glutamine –447 	 62 –284 	 49* 13–14
Proline –367 	 30 –254 	 36* 13–14
Leucine –697 	 57 –423 	 35* 5
Tryptophan –260 	 20 –196 	 19* 6
Methionine –435 	 44 –334 	 35 6
Valine –568 	 90 –462 	 70 6
Citrulline –478 	 110 –333 	 56 6
aArithmetic means 	 se of the currents (in A/cm2) generated
by the respective amino acids (20 mm). *Statistically significant
difference between pdk1hm and pdk1wt mice, n  number of mice
studied.
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tamine, or l-proline, respectively, to the luminal fluid
significantly decreased PDbl in both pdk1
hm and pdk1wt
mice, an effect significantly smaller in pdk1hm than in
pdk1wt mice (Fig. 3).
To assess the abundance of major amino acid trans-
porter proteins expressed in the brush border mem-
brane of the proximal tubule, immunoblotting was
performed with isolated brush border membranes from
kidney. A reduced abundance of the major renal Na-
dependent amino acid transporter for neutral amino
acids, B0AT1 (SLC6A19), was found (Fig. 4). In paral-
lel, the abundance of the Na-dependent glutamate
transporter EAAC1/EAAT3 (SLC1A1) was decreased.
Expression of the b0,AT (SLC7A9) protein, the cata-
lytic subunit of system b0, responsible for the reab-
sorption of cationic amino acids and cystine, was also
reduced. However, expression of the Na, proline
cotransporter SIT (SLC6A20) was enhanced in the
pdk1hm kidney. Thus, at least in the kidney, decreased
expression of several major renal amino acid transport-
ers contributes to the impaired amino acid reabsorp-
tion in PDK1 hypomorphic mice.
More experiments were performed to elucidate the
plasma concentrations and renal excretion of the
amino acids. As evident from Table 2, plasma concen-
tration of none of the amino acids was significantly
different between pdk1hm and pdk1wt mice. Table 3
shows the urinary excretion of creatinine and amino
acids. The average daily urinary creatinine excretion
was not significantly different between pdk1hm mice
(17.6	1.2 g/24 h/g body wt) and pdk1wt mice
(15.7	0.7 g/24 h/g body wt). To account for individ-
ual variations of urinary concentration, the daily uri-
nary excretion of individual amino acids was divided by
the respective daily creatinine excretion. As indicated
in Table 3, renal excretions of several amino acids were
larger in pdk1hm than in pdk1wt mice, differences reach-
ing statistical significance for proline, valine, guanidi-
noacetate, methionine, phenylalanine, citrulline, glu-
tamine/glutamate, and tryptophan.
DISCUSSION
As reported (37), PDK1 hypomorphic mice (pdk1hm)
are significantly smaller than their age- and sex-
matched WT littermates (pdk1wt). Evidence suggested
that the decrease of body mass is the result of smaller
cell volumes and is not due to a decrease in cell number
(37). In theory, a decrease of cell volume could be due
to lack of nutrients, as concentrative uptake of amino
acids leads to cell swelling and subsequent stimulation
of protein synthesis (38–40, 55). Accordingly, the
decreased cell volume could be due to impaired nutri-
ent uptake.
Moreover, insufficient dietary supply or defective
renal or intestinal uptake of amino acids is typically
paralleled by delayed growth (56–60). Thus, the im-
paired intestinal uptake and renal retention of amino
acids could contribute to the growth defect of the
PDK1-deficient mice. On the other hand, food and
water intake was not decreased in PDK1-deficient mice,
further highlighting the significance of impaired intes-
tinal absorption.
According to the Ussing chamber experiments, elec-
trogenic transport of phenylalanine, cysteine, glu-
tamine, proline, leucine, and tryptophan is impaired.
Previous in vitro studies revealed the stimulating effect of
the SGK isoforms and/or PKB on the amino acid trans-
porters SN1 (SLC38A3, SNAT3) (11), ASCT2 (SLC1A5)
(61), EAAT1 (SLC1A3) (12), EAAT2 (SLC1A2) (13),
EAAT3 (SLC1A1) (14), EAAT4 (SLC1A6) (15), and
EAAT5 (SLC1A7) (16). It is possible that other trans-
porters may also be targets of these kinases. The profile
Figure 3. Effect of amino acids on the potential difference
across the basolateral cell membrane of straight proximal
tubules. A, B) Original tracings illustrating the effect of the
luminal application of 20 mM phenylalanine (Phe), glu-
tamine (GLN), and proline (PRO) in the presence of the K
channel blocker Ba2 (1 mM) on the potential difference across the basolateral cell membrane of straight proximal tubules
(PDbl) from PDK1 hypomorphic mice (pdk1
hm) and WT littermates (pdk1wt). C) Arithmetic means 	 se of the depolarization
of the basolateral cell membrane from pdk1hm mice (open columns) and pdk1wt mice (filled columns) following the luminal
replacement of 20 mM mannitol with 20 mM phenylalanine (n5 pdk1hm and 6 pdk1wt), glutamine (n5 pdk1hm and 5 pdk1wt)
or proline (n3 pdk1hm and 3 pdk1wt). *Statistically significant difference between pdk1hm and pdk1wt mice.
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of amino acids in urine and the reduction observed in
transport-induced currents for several amino acids
point to the involvement of more than one amino acid
transport system (41). Patients with mutations in either
B0AT1 (SLC6A19) or b0,AT (SLC7A9) and rBAT
(SLC3A1) suffer from Hartnup disorder or cystinuria.
Both diseases are characterized by the impaired renal
and intestinal transport of neutral amino acids such as
phenylalanine and leucine or cationic amino acids and
cystine, respectively (47, 48, 62, 63) Accordingly, the
reduction in B0AT1 (SLC6A19) expression correlates
with the loss of leucine, phenylalanine, and glutamine.
Na-dependent leucine absorption occurs in the kidney
via several systems, including the low-affinity system B0
(B0AT1, SLC6A19) in the initial part of the proximal
tubule and probably related but unidentified members
of the same gene family. XT2 (SLC6A18) and XT3, two
related orphan transporters with no clearly established
transport function (46), have been observed in the late
proximal tubule. The electrophysiological measure-
ments in the late proximal tubule indicated that amino
acid-induced currents were smaller in the pdk1hm mice,
suggesting that not only a reduction of B0AT1
(SLC6A19) expression in the initial proximal tubule
but also reduced function (and/or expression) of these
putative amino acid transporters may contribute to the
observed aminoaciduria and reduced currents. The
relatively high urinary loss of methionine and valine
may result from the fact that no compensatory mecha-
nisms exist. In contrast, the increased abundance of the
SIT transporter may point to a compensatory mecha-
nism. SIT (SLC6A20) is mainly expressed in the late
proximal tubule; it appears to transport particularly
imino amino acids and belongs to the same SLC6
family of amino acid transporters as B0AT1 (SLC6A19)
(44–46). Surprisingly, reduced abundance of the
b0,AT (SLC7A9) subunit of system b0, did not induce
urinary loss of its typical substrates arginine, lysine, and
cystine. Again, the observed decrease in protein abun-
dance may not adequately mirror the actual activity in
the brush border membrane. Other transport systems
that may compensate for loss of b0, activity are pres-
ently unknown. The increased abundance of SIT may
indicate that regulation of amino acid transporters by
PDK1 does not affect all amino acid transporters.
The SGK kinase isoforms stimulate the voltage-gated
K channel complex KCNE1/KCNQ1 (64), which con-
TABLE 2. Plasma concentrations of amino acids in pdk1hmand
pdk1wt micea
pdk1 wt pdk1 hm
Glycine 275.4 	 29.4 279.8 	 32.7
Alanine 398.9 	 64.7 375.7 	 54.8
Aminobutyrate 23.2 	 2.7 18.9 	 1.6
Serine 38.7 	 5.9 34.9 	 5.4
Proline 53.2 	 11.7 66.2 	 16.1
Valine 223.2 	 28.8 269.5 	 36.5
Threonine 31.3 	 6.0 37.3 	 6.7
5-Oxoproline 15.9 	 1.6 16.5 	 1.3
Leucineisoleucine 216.0 	 23.7 250.0 	 32.8
Asparagine 34.2 	 4.3 43.3 	 5.6
Methionine 71.5 	 11.1 83.2 	 11.4
Histidine 33.9 	 2.2 32.5 	 1.7
Citrulline 53.4 	 4.3 55.6 	 4.5
Phenylalanine 110.8 	 12.8 118.2 	 16.7
Methylhistidine 44.3 	 2.6 43.6 	 2.3
Tyrosine 140.9 	 21.2 138.2 	 17.1
Aspartate 23.7 	 3.7 24.7 	 4.5
Glutamate/glutamine 71.5 	 8.1 60.3 	 8.3
Tryptophan 20.1 	 2.2 18.2 	 2.2
Aminoadipate 5.1 	 0.9 6.8 	 1.3
N-Acetylasparaginic acid 2.1 	 0.4 1.6 	 0.3
Ornithine 49.2 	 6.4 70.4 	 12.8
aArithmetic means 	 se (n11) of the individual amino acid
concentrations in plasma (m) from PDK1 hypomorphic (pdk1hm)
mice and wild type littermates (pdk1wt).
Figure 4. Abundance of amino acid transporters in kidney
brush border membrane. Upper panel) Immunoblots for
b0,AT (SLC7A9), SIT (SLC6A20), EAAC1 (SLC1A1), B0AT1
(SLC6A19) amino acid transporters, and actin demonstrate
the significant reduction in protein abundance of b0,AT,
EAAC1, B0AT1, and increased expression of SIT amino acid
transporters in the renal brush border membrane of pdk1hm
mice. Lower panel) Bar graphs summarizing quantification of
amino acid transporter abundance normalized for loading
with actin (ratio transporter/actin). *Statistically significant
differences between pdk1wt (open columns) and pdk1hm
(open columns) mice (n5 for each genotype).
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tributes to maintenance of the potential difference
across the apical cell membrane of the renal proximal
tubule (53, 65), a critical driving force for electrogenic
amino acid transport (66, 67). K channels similarly
tune intestinal transport of amino acids (68). The SGK
kinase isoforms further stimulate the Na/K-ATPase
(69–72), which is required to maintain the chemical
driving force for Na coupled nutrient transport (68).
Thus, decreased PDK1 activity could modify nutrient
transport indirectly by compromising the driving
forces. The potential difference across the basolateral
cell membrane of proximal renal tubules was, however,
not significantly different between pdk1hm and pdk1wt
mice. Moreover, a decreased K channel activity should
enhance and not decrease the depolarization following
addition of substrates for Na coupled transport. Thus,
the blunted depolarization in pdk1hm mice reflects
decreased electrogenic amino acid transport rather
than decreased K channel activity.
PDK1 may not only stimulate the transport of amino
acids, but may participate in the regulation of further
nutrients. SGK1 has been shown to stimulate activity of
the Na-glucose cotransporter SGLT1 (SLC5A1) (73)
and the facilitative Glc transporter GLUT1 (SLC2A1)
(74). It has also been shown to stimulate the Na,
glucose dicarboxylate cotransporter NaDC-1 (SLC13A2)
(75) and the creatine transporter CreaT (SLC6A8) (76).
Any impairment of renal electrolyte excretion by
blunted stimulation through PDK1 may be compen-
sated for by enhanced stimulation through other mech-
anisms. In fact, despite the powerful stimulating effect
of SGK1 on the renal epithelial Na channel ENaC (77,
78), complete knockout of SGK1 leads to only moder-
ate impairment of renal Na retention, which is dis-
closed only after exposure to a salt-deficient diet (79).
The mild reduction in transport rates observed here
may be explained by the only moderate decrease in
transport function compared with the loss of function
mutations or knockout leading to severe loss of the
respective amino acids (47, 48, 62, 63, 80). It should be
kept in mind that the mice still express PDK1, and thus
that PDK1-dependent regulation of amino acid trans-
port is not completely disrupted in those mice.
The defective intestinal and renal transport of amino
acids did not lead to gross alterations of plasma amino
acid concentrations. Apparently, the enhanced food
intake per body weight compensates for the renal loss
of amino acids and maintains extracellular amino acid
concentrations sufficient for cellular uptake. Needless
to say, the availability of amino acids in extracellular
fluid does not preclude impairment of cellular amino
acid uptake in PDK1-deficient animals through modifi-
cation of amino acid transport in nonpolarized cells.
In conclusion, the PDK1 hypomorphic mice display
moderate impairment of amino acid transport, which
presumably contributes to the delayed growth of those
mice. The observations described here disclose a novel
player in the regulation of intestinal and renal nutrient
transport.
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